FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mathias Berger

Research Profile

Disorders

Physiology

Geographic Areas

Germany

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Claus Normann; Mathias Berger; Lukas Frase; Christoph Nissen
Steroid-responsive depression.
Mathias Berger; C Schneller; Wolfgang Maier
[Work, mental disorders and burnout: concepts and developments in diagnostics, prevention and therapy].
Claus M Gross; Mathias Berger; Armin Flubacher; Michael Frotscher; Inga Herpfer; Andrea Heyer; Klaus Lieb; Marie Scheller; Stefanie Tinnes; Carola A Haas
Early life stress stimulates hippocampal reelin gene expression in a sex-specific manner: evidence for corticosterone-mediated action.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mathias Berger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Claus Normann; Mathias Berger; Lukas Frase; Christoph Nissen
Steroid-responsive depression.
BMJ case reports 2013;2013():.
2012: Mathias Berger; C Schneller; Wolfgang Maier
[Work, mental disorders and burnout: concepts and developments in diagnostics, prevention and therapy].
Der Nervenarzt 2012;83(11):1364-72.
2012: Claus M Gross; Mathias Berger; Armin Flubacher; Michael Frotscher; Inga Herpfer; Andrea Heyer; Klaus Lieb; Marie Scheller; Stefanie Tinnes; Carola A Haas
Early life stress stimulates hippocampal reelin gene expression in a sex-specific manner: evidence for corticosterone-mediated action.
Hippocampus 2012;22(3):409-20.
2011: I Zobel; S Kech; Dietrich van Calker; Petra Dykierek; Mathias Berger; R Schneibel; Elisabeth Schramm
Long-term effect of combined interpersonal psychotherapy and pharmacotherapy in a randomized trial of depressed patients.
Acta psychiatrica Scandinavica 2011;123(4):276-82.
2011: Elisabeth Schramm; Ingo Zobel; Petra Dykierek; Sabine Kech; Eva-Lotta Brakemeier; Anne Külz; Mathias Berger
Cognitive behavioral analysis system of psychotherapy versus interpersonal psychotherapy for early-onset chronic depression: a randomized pilot study.
Journal of affective disorders 2011;129(1-3):109-16.
2011: Elisabeth Schramm; Ingo Zobel; Mathias Berger; Martin Hautzinger; Levente Kriston; Martin Härter
Comparative efficacy of the Cognitive Behavioral Analysis System of Psychotherapy versus supportive psychotherapy for early onset chronic depression: design and rationale of a multisite randomized controlled trial.
BMC psychiatry 2011;11():134.
2011: Eva-Lotta Brakemeier; Vera Engel; Elisabeth Schramm; Ingo Zobel; Teresa Schmidt; Martin Hautzinger; Mathias Berger; Claus Normann
Feasibility and outcome of cognitive behavioral analysis system of psychotherapy (CBASP) for chronically depressed inpatients: a pilot study.
Psychotherapy and psychosomatics 2011;80(3):191-4.
2011: Ulrich Voderholzer; R Dersch; H H Dickhut; A Herter; T Freyer; Mathias Berger
Physical fitness in depressive patients and impact of illness course and disability.
Journal of affective disorders 2011;128(1-2):160-4.
2010: Isaac Bermejo; Levente Kriston; Frank Schneider; Wolfgang Gaebel; Ulrich Hegerl; Mathias Berger; Martin Härter
Sick leave and depression - determining factors and clinical effect in outpatient care.
Psychiatry research 2010;180(2-3):68-73.
2010: Alexandra Philipsen; Erika Graf; Ludger Tebartz van Elst; Thomas Jans; Andreas Warnke; Bernd Hesslinger; Dieter Ebert; Manfred Gerlach; Swantje Matthies; Michael Colla; Christian Jacob; Esther Sobanski; Barbara Alm; Michael Rösler; Gabriele Ihorst; Silke Gross-Lesch; Laura Gentschow; Bernhard Kis; Michael Huss; Klaus Lieb; Michael Schlander; Mathias Berger
Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial.
Attention deficit and hyperactivity disorders 2010;2(4):203-12.
2010: Ingo Zobel; Doris Werden; Hans Linster; Petra Dykierek; Tobias Drieling; Mathias Berger; Elisabeth Schramm
Theory of mind deficits in chronically depressed patients.
Depression and anxiety 2010;27(9):821-8.
2010: Isaac Bermejo; Levente Kriston; Mathias Berger; Martin Härter
[Outpatient depression treatment--comparative analysis of general practitioners', psychiatrists' and psychotherapists' treatment strategies].
Psychotherapie, Psychosomatik, medizinische Psychologie 2010;60(8):326-8.
2010: Birgit Janssen; S Ludwig; H Eustermann; Ralph Menke; M Haerter; Mathias Berger; G Adam; U Seemann; W Kissling; Wolfgang Gaebel
Improving outpatient treatment in schizophrenia: effects of computerized guideline implementation--results of a multicenter-study within the German research network on schizophrenia.
European archives of psychiatry and clinical neuroscience 2010;260(1):51-7.
2010: Dieter Riemann; Kai Spiegelhalder; Bernd Feige; Ulrich Voderholzer; Mathias Berger; Michael Perlis; Christoph Nissen
The hyperarousal model of insomnia: a review of the concept and its evidence.
Sleep medicine reviews 2010;14(1):19-31.
2010: C Normann; J Boldt; G Maio; Mathias Berger
[Options, limits and ethics of pharmacological neuroenhancement].
Der Nervenarzt 2010;81(1):66-74.
2009: Henrik Walter; Mathias Berger; Knut Schnell
Neuropsychotherapy: conceptual, empirical and neuroethical issues.
European archives of psychiatry and clinical neuroscience 2009;259 Suppl 2():S173-82.
2009: Isaac Bermejo; Mathias Berger; Levente Kriston; Martin Härter
[Is patient's satisfaction with inpatient depression treatment related to their German language proficiency?].
Psychiatrische Praxis 2009;36(6):279-85.
2009: Michael Schredl; Mathias Berger; Dieter Riemann
The effect of trimipramine on dream recall and dream emotions in depressive outpatients.
Psychiatry research 2009;167(3):279-86.
2009: Dieter Riemann; C Kloepfer; Mathias Berger
Functional and structural brain alterations in insomnia: implications for pathophysiology.
The European journal of neuroscience 2009;29(9):1754-60.
2009: Mathias Berger; E L Brakemeier; C Klesse; E Schramm
[Affective disorders. The significance of psychotherapeutic approaches].
Der Nervenarzt 2009;80(5):540, 542-4, 546-8 passim.
2009: Dietrich van Calker; Ingo Zobel; Petra Dykierek; Christoph Michael Deimel; Sabine Kech; Klaus Lieb; Mathias Berger; Elisabeth Schramm
Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
Journal of affective disorders 2009;114(1-3):243-53.
2009: Isaac Bermejo; Frank Schneider; Levente Kriston; Wolfgang Gaebel; Victor Perez; Mathias Berger; Martin Härter
Improving outpatient care of depression by implementing practice guidelines: a controlled clinical trial.
International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua 2009;21(1):29-36.
2008: M Wündrich; J Peters; A Philipsen; M Kopasz; Mathias Berger; U Voderholzer
[Clinical teaching with simulated patients in psychiatry and psychotherapy. A controlled pilot study].
Der Nervenarzt 2008;79(11):1273-4, 1276, 1278, passim.
2008: Thomas Schierenbeck; Dieter Riemann; Mathias Berger; Magdolna Hornyak
Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana.
Sleep medicine reviews 2008;12(5):381-9.
2008: Ingo Zobel; Mathias Berger; Arian Karim; Sabine Kech; Elisabeth Schramm
[The adherence of clinical management in a randomized controlled trial. Results from a psychotherapy study].
Psychotherapie, Psychosomatik, medizinische Psychologie 2008;58(9-10):395-402.
2008: Elisabeth Schramm; Daniel Schneider; Ingo Zobel; Dietrich van Calker; Petra Dykierek; Sabine Kech; Martin Härter; Mathias Berger
Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients.
Journal of affective disorders 2008;109(1-2):65-73.
2008: E-L Brakemeier; C Normann; Mathias Berger
[The etiopathogenesis of unipolar depression. Neurobiological and psychosocial factors].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2008;51(4):379-91.
2008: Martin Härter; C Klesse; Isaac Bermejo; M Lelgemann; S Weinbrenner; Günter Ollenschläger; I Kopp; Mathias Berger
[Development of national guidelines for depression].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2008;51(4):451-7.
2008: Daniel Schneider; Ingo Zobel; Martin Härter; Sabine Kech; Mathias Berger; Elisabeth Schramm
[Is interpersonal psychotherapy a woman specific method? Results of a randomized controlled study].
Psychotherapie, Psychosomatik, medizinische Psychologie 2008;58(1):23-31.
2007: Klaus Stamm; Hans Joachim Salize; Martin Härter; Silke Brand; Petra Sitta; Mathias Berger; Wolfgang Gaebel; Frank Schneider
[Cost predictors of depressive inpatient episodes in Germany. The health insurer's point of view].
Der Nervenarzt 2007;78(6):665-71.
2007: Elisabeth Schramm; Dietrich van Calker; Petra Dykierek; Klaus Lieb; Sabine Kech; Ingo Zobel; Rainer Leonhart; Mathias Berger
An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results.
The American journal of psychiatry 2007;164(5):768-77.
2007: Ulrich Voderholzer; Dieter Riemann; Christine Huwig-Poppe; Anne Katrin Kuelz; Andreas Kordon; Katharina Bruestle; Mathias Berger; Fritz Hohagen
Sleep in obsessive compulsive disorder: polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency.
European archives of psychiatry and clinical neuroscience 2007;257(3):173-82.
2006: Christoph Nissen; Ann E Power; Eric A Nofzinger; Bernd Feige; Ulrich Voderholzer; Corinna Kloepfer; Bernhard Waldheim; Marc-Philipp Radosa; Mathias Berger; Dieter Riemann
M1 muscarinic acetylcholine receptor agonism alters sleep without affecting memory consolidation.
Journal of cognitive neuroscience 2006;18(11):1799-807.
2006: Christoph Nissen; Eric A Nofzinger; Bernd Feige; Bernhard Waldheim; Marc-Philipp Radosa; Dieter Riemann; Mathias Berger
Differential effects of the muscarinic M1 receptor agonist RS-86 and the acetylcholine-esterase inhibitor donepezil on REM sleep regulation in healthy volunteers.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(6):1294-300.
2006: Martin Härter; Isaac Bermejo; Günter Ollenschläger; Frank Schneider; Wolfgang Gaebel; Victor Perez; Wilhelm Niebling; Mathias Berger
Improving quality of care for depression: the German Action Programme for the implementation of evidence-based guidelines.
International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua 2006;18(2):113-9.
2006: Petra Sitta; Silke Brand; Frank Schneider; Wolfgang Gaebel; Mathias Berger; Erik Farin; Martin Härter
[Duration of inpatient depression treatment--fair benchmarking between hospitals].
Psychotherapie, Psychosomatik, medizinische Psychologie 2006;56(3-4):128-37.
2006: E Schramm; F Caspar; Mathias Berger
[A specific therapy for chronic depression. McCullough's Cognitive Behavioral Analysis System of Psychotherapy].
Der Nervenarzt 2006;77(3):355-70; quiz 371.
2006: Michael Hüll; Mathias Berger; Michael T Heneka
Disease-modifying therapies in Alzheimer's disease: how far have we come?
Drugs 2006;66(16):2075-93.
2005: Frank Schneider; Martin Härter; Silke Brand; Petra Sitta; Ralph Menke; Ursula Hammer-Filipiak; Ralf Kudling; Andrea Heindl; Kurt Herold; Ulrich Frommberger; Olivier Elmer; Günter Hetzel; Gabriele Witt; Manfred Wolfersdorf; Mathias Berger; Wolfgang Gaebel
Adherence to guidelines for treatment of depression in in-patients.
The British journal of psychiatry : the journal of mental science 2005;187():462-9.
2005: Magdolna Hornyak; Marta Kopasz; Mathias Berger; Dieter Riemann; Ulrich Voderholzer
Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome.
The Journal of clinical psychiatry 2005;66(9):1139-45.
2005: Silke Brand; Martin Härter; Petra Sitta; Dietrich van Calker; Ralph Menke; A Heindl; K Herold; R Kudling; C Luckhaus; U Rupprecht; Dirk Sanner; D Schmitz; Elisabeth Schramm; Mathias Berger; Wolfgang Gaebel; Frank Schneider
[Data supporting quality circle management of inpatient depression treatment].
Der Nervenarzt 2005;76(7):865-6, 868-72, 873-4.
2005: Christoph Nissen; Bernd Feige; Eric A Nofzinger; Dieter Riemann; Mathias Berger; Ulrich Voderholzer
Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine.
Journal of sleep research 2005;14(2):207-8.
2005: Birgit Janssen; Stefan Weinmann; Mathias Berger; Martin Härter; Tilo Held; M Leipert; H J Luderer; M Schwarz; T Steinert; Wolfgang Gaebel
[Guideline conformity and outcome of inpatient treatment for schizophrenia. A clinical comparison].
Der Nervenarzt 2005;76(3):315-26.
2005: Frank Schneider; Ralph Menke; Martin Härter; Hans Joachim Salize; Birgit Janssen; F Bergmann; Mathias Berger; Wolfgang Gaebel
[Are bonus systems applicable to guideline-oriented depression treatment provided by general practitioners and neurologists?].
Der Nervenarzt 2005;76(3):308-14.
2005: Peter M Wehmeier; Michael Kluge; Athanasios Maras; Dieter Riemann; Mathias Berger; R Kohnen; Ralf W Dittmann; Wagner F Gattaz
Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
Pharmacopsychiatry 2005;38(1):13-6.
2004: Martin Härter; Petra Sitta; F Keller; R Metzger; W Wiegand; G Schell; Rolf-Dieter Stieglitz; Manfred Wolfersdorf; M Felsenstein; Mathias Berger
[Psychiatric-psychotherapeutic inpatient treatment for depression. Process and outcome quality based on a model project in Baden-Wurttemberg].
Der Nervenarzt 2004;75(11):1083-91.
2004: Horst Gann; Dietrich van Calker; Bernd Feige; Oliver Cloot; Rigo Brück; Mathias Berger; Dieter Riemann
Polysomnographic comparison between patients with primary alcohol dependency during subacute withdrawal and patients with a major depression.
European archives of psychiatry and clinical neuroscience 2004;254(4):263-71.
2004: Ulrich Voderholzer; Fritz Hohagen; Torsten Klein; Julia Jungnickel; Clemens Kirschbaum; Mathias Berger; Dieter Riemann
Impact of sleep deprivation and subsequent recovery sleep on cortisol in unmedicated depressed patients.
The American journal of psychiatry 2004;161(8):1404-10.
2004: Katrin Barkow; Reinhard Heun; T Bedirhan Ustün; Mathias Berger; Isaac Bermejo; Wolfgang Gaebel; Martin Härter; Frank Schneider; Rolf-Dieter Stieglitz; Wolfgang Maier
Identification of somatic and anxiety symptoms which contribute to the detection of depression in primary health care.
European psychiatry : the journal of the Association of European Psychiatrists 2004;19(5):250-7.
2004: Hans Joachim Salize; Klaus Stamm; Matthias Schubert; Frank Bergmann; Martin Härter; Mathias Berger; Wolfgang Gaebel; Frank Schneider
[Cost of care for depressive disorders in primary and specialized care in Germany].
Psychiatrische Praxis 2004;31(3):147-56.
2004: Elisabeth Schramm; Dietrich van Calker; Mathias Berger
[Efficacy and therapeutic factors of interpersonal psychotherapy for depressed inpatients - results of a pilot study].
Psychotherapie, Psychosomatik, medizinische Psychologie 2004;54(2):65-72.
2004: Frank Schneider; Sandra Kratz; Isaac Bermejo; Ralph Menke; Christoph Mulert; Ulrich Hegerl; Mathias Berger; Wolfgang Gaebel; Martin Härter
Insufficient depression treatment in outpatient settings.
German medical science : GMS e-journal 2004;2():Doc01.
2004: Birgit Janssen; Stefan Weinmann; Mathias Berger; Wolfgang Gaebel
Validation of polypharmacy process measures in inpatient schizophrenia care.
Schizophrenia bulletin 2004;30(4):1023-33.
2003: Ralph Menke; Frank Schneider; Martin Härter; Hans Joachim Salize; Mathias Berger; Wolfgang Gaebel
[Cost optimization of the outpatient management of depression].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2003;97 Suppl 4():74-9.
2003: Frank Schneider; Martin Härter; Sandra Kratz; Isaac Bermejo; Christoph Mulert; Victor Perez; Wolfgang Gaebel; Mathias Berger
[Subjectively-perceived inappropriate treatment of depressed patients in general and psychiatric practice].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2003;97 Suppl 4():57-66.
2003: Sandra Kratz; Martin Härter; Isaac Bermejo; Mathias Berger; Frank Schneider; Wolfgang Gaebel
[Reason for encounter and diagnosis of depression in patients in general practice].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2003;97 Suppl 4():50-6.
2003: Isaac Bermejo; Sandra Kratz; Frank Schneider; Wolfgang Gaebel; Christoph Mulert; Victor Perez; Mathias Berger; Martin Härter
[Agreement in physicians' and patients' assessment of depressive disorders].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2003;97 Suppl 4():44-9.
2003: Martin Härter; Isaac Bermejo; Frank Schneider; Sandra Kratz; Wolfgang Gaebel; Victor Perez; Wilhelm Niebling; Mathias Berger
[Clinical practice guidelines for the diagnosis and therapy of depressive disorders in primary care].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2003;97 Suppl 4():16-35.
2003: Martin Härter; Isaac Bermejo; Frank Schneider; Wolfgang Gaebel; Wilhelm Niebling; Mathias Berger
[Comprehensive ambulatory care quality management for patients with depressive disorders].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2003;97 Suppl 4():9-15.
2003: Elisabeth Nyberg; Rolf-Dieter Stieglitz; Ulrich Frommberger; Mathias Berger
[Psychological disorders after severe occupational accidents].
Versicherungsmedizin / herausgegeben von Verband der Lebensversicherungs-Unternehmen e.V. und Verband der Privaten Krankenversicherung e.V 2003;55(2):76-81.
2003: Dieter Riemann; Magdolna Hornyak; Ulrich Voderholzer; Mathias Berger
[Algorithms for diagnosis and therapy of sleep disorders in general practice].
MMW Fortschritte der Medizin 2003;145 Suppl 2():55-60.
2003: Dieter Riemann; Ulrich Voderholzer; Mathias Berger
[Non-restorative sleep and insomnia. Diagnostic and therapeutic options for psychiatry and psychotherapy].
Der Nervenarzt 2003;74(5):450-67; quiz 468-9.
2003: Ulrich Voderholzer; Gabriele Valerius; LO Schaerer; Dieter Riemann; Henner Giedke; Frank Schwärzler; Mathias Berger; M Wiegand
Is the antidepressive effect of sleep deprivation stabilized by a three day phase advance of the sleep period? A pilot study.
European archives of psychiatry and clinical neuroscience 2003;253(2):68-72.
2003: Mathias Berger; Dietrich van Calker; Dieter Riemann
Sleep and manipulations of the sleep-wake rhythm in depression.
Acta psychiatrica Scandinavica. Supplementum 2003;(418):83-91.
2002: Klaus Lieb; Katrin Ahlvers; Katharina Dancker; Stefan Strohbusch; Martin Reincke; Bernd Feige; Mathias Berger; Dieter Riemann; Ulrich Voderholzer
Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(6):1041-9.
2002: Ulrich Voderholzer; Dieter Riemann; Horst Gann; Magdolna Hornyak; Freimut D Juengling; Martin Schumacher; Martin Reincke; Axel von Herbay; Seiji Nishino; Emmanuel Mignot; Mathias Berger; Klaus Lieb
Transient total sleep loss in cerebral Whipple's disease: a longitudinal study.
Journal of sleep research 2002;11(4):321-9.
2002: Klaus Lieb; Inga Herpfer; Bernd L Fiebich; Mathias Berger
[Substance P-antagonists as a new class of antidepressant drugs].
Deutsche medizinische Wochenschrift (1946) 2002;127(48):2563-5.
2002: Dieter Ebert; Mathias Berger; Bernd Hesslinger
[ADHD as a risk factor for delinquency and personality disorders? Recognizing the patient at risk].
MMW Fortschritte der Medizin 2002;144(47):31-3.
2002: Ingrid Mühlhauser; Peter T Sawicki; M Blank; H Overmann; Bernd Richter; Mathias Berger
Reliability of causes of death in persons with Type I diabetes.
Diabetologia 2002;45(11):1490-7.
2002: Isaac Bermejo; Antonia Lohmann; Mathias Berger; Martin Härter
[Barriers and need for support in the primary care of depressive patients].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2002;96(9):605-13.
2002: Dieter Riemann; Ulrich Voderholzer; Stefan Cohrs; Andrea Rodenbeck; Göran Hajak; Eckart Rüther; M H Wiegand; Gregor Laakmann; Thomas C Baghai; W Fischer; M Hoffmann; Fritz Hohagen; G Mayer; Mathias Berger
Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
Pharmacopsychiatry 2002;35(5):165-74.
2002: R Linkeschova; M Raoul; U Bott; Mathias Berger; M Spraul
Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(9):746-51.
2002: Bernd Hesslinger; Martin Härter; Jürgen Barth; D Klecha; C Bode; Jörg Walden; Jürgen Bengel; Mathias Berger
[Comorbidity of depressive disorders and cardiovascular diseases. Implications for diagnosis, pharmaco- and psychotherapy].
Der Nervenarzt 2002;73(3):205-17; quiz 218.
2002: Bernd Feige; Ulrich Voderholzer; Dieter Riemann; Ralf W Dittmann; Fritz Hohagen; Mathias Berger
Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(2):246-58.
2002: Ulrich Voderholzer; Gesa Weske; Sabine Ecker; Dieter Riemann; Horst Gann; Mathias Berger
Neurobiological findings before and during successful lithium therapy of a patient with 48-hour rapid-cycling bipolar disorder.
Neuropsychobiology 2002;45 Suppl 1():13-9.
2002: Dieter Riemann; Ulrich Voderholzer; Mathias Berger
Sleep and sleep-wake manipulations in bipolar depression.
Neuropsychobiology 2002;45 Suppl 1():7-12.
2002: Klaus Lieb; Yvonne Treffurth; Mathias Berger; Bernd L Fiebich
Substance P and affective disorders: new treatment opportunities by neurokinin 1 receptor antagonists?
Neuropsychobiology 2002;45 Suppl 1():2-6.
2002: T P Neuvians; Mathias Berger
Diabetes care in cats and dogs.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(1):77-9.
2002: Christoph Trautner; Burkhard Haastert; Guido Giani; Mathias Berger
Amputations and diabetes: a case-control study.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(1):35-40.
2001: Martin Härter; Isaac Bermejo; Astrid Aschenbrenner; Mathias Berger
[Analysis and evaluation of current guidelines for diagnosis and treatment of depressive disorders:].
Fortschritte der Neurologie-Psychiatrie 2001;69(9):390-401.
2001: Gesa Weske; Mathias Berger; Dieter Riemann; Ulrich Voderholzer
[Neurobiological findings in a patient with 48-hour rapid cycling bipolar affective disorder. A case report].
Der Nervenarzt 2001;72(7):549-54.
2001: Dieter Riemann; Mathias Berger; Ulrich Voderholzer
Sleep and depression--results from psychobiological studies: an overview.
Biological psychology 2001;57(1-3):67-103.
2001: Ulrich Voderholzer; Dieter Riemann; Magdolna Hornyak; Jutta Backhaus; Bernd Feige; Mathias Berger; Fritz Hohagen
A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
European archives of psychiatry and clinical neuroscience 2001;251(3):117-23.
2001: Gesa Weske; Ulrich Voderholzer; Dieter Riemann; Mathias Berger
[Sleep disorders. Differential diagnosis and therapy in general practice].
MMW Fortschritte der Medizin 2001;143 Suppl 2():5-8, 10, 12.
2001: Christoph Nissen; Bernd Feige; A König; Ulrich Voderholzer; Mathias Berger; Dieter Riemann
Delta sleep ratio as a predictor of sleep deprivation response in major depression.
Journal of psychiatric research 2001;35(3):155-63.
2001: Christoph Trautner; Burkhard Haastert; M Spraul; Guido Giani; Mathias Berger
Unchanged incidence of lower-limb amputations in a German City, 1990-1998.
Diabetes care 2001;24(5):855-9.
2001: Rolf-Dieter Stieglitz; Ulrich Frommberger; E B Foa; Mathias Berger
Evaluation of the German version of the PTSD Symptom Scale (PSS).
Psychopathology 2001;34(3):128-33.
2001: R Wolf; Petra Dykierek; Wagner F Gattaz; Athanasios Maras; R Kohnen; Ralf W Dittmann; M Geuppert; Dieter Riemann; Mathias Berger
Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
Pharmacopsychiatry 2001;34(2):60-5.
2001: Christoph Trautner; Burkhard Haastert; Guido Giani; Mathias Berger
Incidence of blindness in southern Germany between 1990 and 1998.
Diabetologia 2001;44(2):147-50.
2001: G Schumann; Francesco Benedetti; Ulrich Voderholzer; Norbert Kammerer; Ulrich M Hemmeter; H W Travers; Bernd L Fiebich; Edith Holsboer-Trachsler; Mathias Berger; Erich Seifritz; Dieter Ebert
Antidepressive response to sleep deprivation in unipolar depression is not associated with dopamine D3 receptor genotype.
Neuropsychobiology 2001;43(3):127-30.
2000: Ingrid Mühlhauser; H Overmann; R Bender; V Jörgens; Mathias Berger
Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy.
Diabetic medicine : a journal of the British Diabetic Association 2000;17(10):727-34.
2000: Ingrid Mühlhauser; Peter T Sawicki; M Blank; H Overmann; R Bender; Mathias Berger
Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy.
Journal of internal medicine 2000;248(4):333-41.
2000: U Bott; S Bott; D Hemmann; Mathias Berger
Evaluation of a holistic treatment and teaching programme for patients with Type 1 diabetes who failed to achieve their therapeutic goals under intensified insulin therapy.
Diabetic medicine : a journal of the British Diabetic Association 2000;17(9):635-43.
2000: Ulrich A Müller; M Femerling; A Risse; Matthias Schumann; G Use; V Jörgens; Mathias Berger
[Self-treatment instruction of patients with type 1 diabetes. Report from hospitals belonging to Working Group for Structured Diabetes Therapy (ASD) in Germany 1998].
Medizinische Klinik (Munich, Germany : 1983) 2000;95(7):359-68.
2000: Bernd Richter; R Bender; Mathias Berger
Effects of on-demand beta2-agonist inhalation in moderate-to-severe asthma. A randomized controlled trial.
Journal of internal medicine 2000;247(6):657-66.
2000: Bernd Richter; Mathias Berger
Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate)
Diabetologia 2000;43(4):528-32.
2000: Michael Schredl; B Weber; D Braus; Wagner F Gattaz; Mathias Berger; Dieter Riemann; Isabella Heuser
The effect of rivastigmine on sleep in elderly healthy subjects.
Experimental gerontology 2000;35(2):243-9.
2000: Michael Berner; A Rüther; Rolf-Dieter Stieglitz; Mathias Berger
[The concept of "evidence-based medicine" in psychiatry. A path to a more rational psychiatry?].
Der Nervenarzt 2000;71(3):173-80.
2000: Bernd Richter; Mathias Berger
Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate) [corrected].
Diabetologia 2000;43(2):254-8.
2000: Peter T Sawicki; R Bender; Mathias Berger; Ingrid Mühlhauser
Non-linear effects of blood pressure and glycosylated haemoglobin on progression of diabetic nephropathy.
Journal of internal medicine 2000;247(1):131-8.
1999: Klaus Lieb; M Maiwald; Mathias Berger; Ulrich Voderholzer
Insomnia for 5 years.
Lancet 1999;354(9194):1966.
1999: Bernd Feige; Ulrich Voderholzer; Dieter Riemann; Fritz Hohagen; Mathias Berger
Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 1999;110(11):1965-74.
1999: Bernd Hesslinger; Claus Normann; Jens M Langosch; Peter Klose; Mathias Berger; Jörg Walden
Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
Journal of clinical psychopharmacology 1999;19(4):310-5.
1999: Mathias Berger; Ingrid Mühlhauser
Diabetes care and patient-oriented outcomes.
JAMA : the journal of the American Medical Association 1999;281(18):1676-8.
1999: R Bender; K H Jöckel; Christoph Trautner; M Spraul; Mathias Berger
Effect of age on excess mortality in obesity.
JAMA : the journal of the American Medical Association 1999;281(16):1498-504.
1999: Ulrich Frommberger; Rolf-Dieter Stieglitz; S Straub; Elisabeth Nyberg; W Schlickewei; EH Kuner; Mathias Berger
The concept of "sense of coherence" and the development of posttraumatic stress disorder in traffic accident victims.
Journal of psychosomatic research 1999;46(4):343-8.
1999: Mathias Berger; V Jörgens; Ingrid Mühlhauser
Rationale for the use of insulin therapy alone as the pharmacological treatment of type 2 diabetes.
Diabetes care 1999;22 Suppl 3():C71-5.
1999: Ulrich A Müller; M Femerling; K M Reinauer; A Risse; M Voss; V Jörgens; Mathias Berger; Ingrid Mühlhauser
Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association).
Diabetes care 1999;22 Suppl 2():B29-34.
1999: Dieter Riemann; A König; Fritz Hohagen; A Kiemen; Ulrich Voderholzer; Jutta Backhaus; J Bunz; B Wesiack; Leopold Hermle; Mathias Berger
How to preserve the antidepressive effect of sleep deprivation: A comparison of sleep phase advance and sleep phase delay.
European archives of psychiatry and clinical neuroscience 1999;249(5):231-7.
1999: M Spraul; A M Schönbach; Ingrid Mühlhauser; Mathias Berger
[Amputations and mortality in elderly insulin-treated patients with type 2 diabetes].
Zentralblatt für Chirurgie 1999;124(6):501-7.
1998: Dieter Ebert; Mathias Berger
Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation.
Psychopharmacology 1998;140(1):1-10.
1998: J S Braun; I Apel; S Schäffer; Martin Schumacher; Mathias Berger
[Delirium during oral therapy of herpes zoster with acyclovir. Case report and brief review of central nervous system side-effects of acyclovir].
Der Nervenarzt 1998;69(11):1015-8.
1998: Claus Normann; Bernd Hesslinger; J Bauer; Mathias Berger; Jörg Walden
[Significance of hepatic cytochrome P450 enzymes for psychopharmacology].
Der Nervenarzt 1998;69(11):944-55.
1998: O Spleiss; Dietrich van Calker; Lars O Schärer; K Adamovic; Mathias Berger; Peter J Gebicke-Haerter
Abnormal G protein alpha(s) - and alpha(i2)-subunit mRNA expression in bipolar affective disorder.
Molecular psychiatry 1998;3(6):512-20.
1998: Ingrid Mühlhauser; H Overmann; R Bender; U Bott; Mathias Berger
Risk factors of severe hypoglycaemia in adult patients with Type I diabetes--a prospective population based study.
Diabetologia 1998;41(11):1274-82.
1998: Heidemarie Hecht; Dietrich van Calker; Mathias Berger; Detlev von Zerssen
Personality in patients with affective disorders and their relatives.
Journal of affective disorders 1998;51(1):33-43.
1998: Ingrid Mühlhauser; H Overmann; R Bender; U Bott; V Jörgens; Christoph Trautner; J Siegrist; Mathias Berger
Social status and the quality of care for adult people with type I (insulin-dependent) diabetes mellitus--a population-based study.
Diabetologia 1998;41(10):1139-50.
1998: Claus Normann; C Brandt; Mathias Berger; Jörg Walden
Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
Pharmacopsychiatry 1998;31(5):201-4.
1998: Peter J Gebicke-Haerter; Klaus Lieb; Peter Illes; Mathias Berger
[Microglia: mechanisms of activation and significance in pathogenesis of neuropsychiatric illnesses].
Der Nervenarzt 1998;69(9):752-62.
1998: Jens M Langosch; M Repp; Mathias Berger; Jörg Walden
Effects of the atypical antidepressant trimipramine on field potentials in the low Mg2+-model in guinea pig hippocampal slices.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1998;8(3):209-12.
1998: Magdolna Hornyak; Ulrich Voderholzer; Fritz Hohagen; Mathias Berger; Dieter Riemann
Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study.
Sleep 1998;21(5):501-5.
1998: Jens M Langosch; Claus Normann; K Schirrmacher; Mathias Berger; Jörg Walden
The influence of (+/-)-kavain on population spikes and long-term potentiation in guinea pig hippocampal slices.
Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 1998;120(3):545-9.
1998: J S Braun; R Geiger; H Wehner; S Schäffer; Mathias Berger
Hepatitis caused by antidepressive therapy with maprotiline and opipramol.
Pharmacopsychiatry 1998;31(4):152-5.
1998: O Spleiss; NG Gourmala; Hendrikus W G M Boddeke; A Sauter; Bernd L Fiebich; Mathias Berger; Peter J Gebicke-Haerter
Cloning of rat HIV-1-chemokine coreceptor CKR5 from microglia and upregulation of its mRNA in ischemic and endotoxinemic rat brain.
Journal of neuroscience research 1998;53(1):16-28.
1998: Ulrich Voderholzer; Jutta Backhaus; Magdolna Hornyak; Fritz Hohagen; Mathias Berger; Dieter Riemann
A 19-h spontaneous sleep period in idiopathic central nervous system hypersomnia.
Journal of sleep research 1998;7(2):101-3.
1998: Martin Bohus; K Schehr; F Berger-Sallawitz; U Novelli-Fischer; Rolf-Dieter Stieglitz; Mathias Berger
[Children of mentally ill parents. A study of problem awareness in clinical routine practice].
Psychiatrische Praxis 1998;25(3):134-8.
1998: U Bott; Ingrid Mühlhauser; H Overmann; Mathias Berger
Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes.
Diabetes care 1998;21(5):757-69.
1998: Bernd Hesslinger; Peter Klose; Claus Normann; Jens M Langosch; Mathias Berger; Jörg Walden
[Adjuvant treatment of schizophrenic illness with carbamazepine].
Fortschritte der Neurologie-Psychiatrie 1998;66(4):145-50.
1998: Peter T Sawicki; Mathias Berger
Pharmacological treatment of diabetic patients with cardiovascular complications.
Journal of internal medicine 1998;243(3):181-9.
1998: Ulrich Voderholzer; Magdolna Hornyak; B Thiel; Christine Huwig-Poppe; A Kiemen; A König; Jutta Backhaus; Dieter Riemann; Mathias Berger; Fritz Hohagen
Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;18(2):112-24.
1998: Horst Gann; A Faulmann; A Kiemen; Torsten Klein; D Ebert; Jutta Backhaus; Magdolna Hornyak; Ulrich Voderholzer; Fritz Hohagen; Mathias Berger; Dieter Riemann
Sleep and the cholinergic rem sleep induction test in patients with primary alcoholism.
Sleep research online : SRO 1998;1(2):92-5.
1998: Ulrich Frommberger; Rolf-Dieter Stieglitz; Elisabeth Nyberg; W Schlickewei; EH Kuner; Mathias Berger
Prediction of posttraumatic stress disorder by immediate reactions to trauma: a prospective study in road traffic accident victims.
European archives of psychiatry and clinical neuroscience 1998;248(6):316-21.
1998: Mathias Berger
[Lipid lowering therapy for primary prevention of coronary heart disease--contra lipid lowering therapy].
Zeitschrift für Kardiologie 1998;87 Suppl 2():210-3.
1998: U Bott; Mathias Berger
[Is it possible to predict the success of an intensified program of insulin therapy?].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1998;():289-313.
1998: Michael Hüll; B L Fiebich; Petra Dykierek; Klaus Schmidtke; Egbert Nitzsche; M Orszagh; Günther Deuschl; E Moser; Martin Schumacher; C Lücking; Mathias Berger; J Bauer
Early-onset Alzheimer's disease due to mutations of the presenilin-1 gene on chromosome 14: a 7-year follow-up of a patient with a mutation at codon 139.
European archives of psychiatry and clinical neuroscience 1998;248(3):123-9.
1998: Petra Dykierek; G Stadtmüller; P Schramm; M Bahro; Dietrich van Calker; D F Braus; P Steigleider; H Löw; Fritz Hohagen; Wagner F Gattaz; Mathias Berger; Dieter Riemann
The value of REM sleep parameters in differentiating Alzheimer's disease from old-age depression and normal aging.
Journal of psychiatric research 1998;32(1):1-9.
1998: O Spleiss; Kurt Appel; Hendrikus W G M Boddeke; Mathias Berger; Peter J Gebicke-Haerter
Molecular biology of microglia cytokine and chemokine receptors and microglial activation.
Life sciences 1998;62(17-18):1707-10.
1998: Rolf-Dieter Stieglitz; Manfred Wolfersdorf; R Metzger; A Ruppe; S Stabenow; C Hornstein; F Keller; G Schell; Mathias Berger
[Inpatient treatment of depressed patents. Conceptual considerations and results of a pilot project for quality assurance in Baden-Württemberg].
Der Nervenarzt 1998;69(1):59-65.
1998: Peter T Sawicki; S Kiwitt; R Bender; Mathias Berger
The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus.
Journal of internal medicine 1998;243(1):49-56.
1998: R Bender; Christoph Trautner; M Spraul; Mathias Berger
Assessment of excess mortality in obesity.
American journal of epidemiology 1998;147(1):42-8.
1997: Klaus Lieb; Bernd L Fiebich; Mathias Berger; J Bauer; Klaus Schulze-Osthoff
The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(10):4952-8.
1997: Claus Normann; Bernd Hesslinger; S Frauenknecht; Mathias Berger; Jörg Walden
Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
Pharmacopsychiatry 1997;30(6):263-5.
1997: Klaus Lieb; Peter Vaith; Mathias Berger; J Bauer
[Systemic immunologic diseases as differential diagnosis in psychiatry].
Der Nervenarzt 1997;68(9):696-707.
1997: B Lubrich; Y Patishi; Ora Kofman; Galila Agam; Mathias Berger; Robert H Belmaker; Dietrich van Calker
Lithium-induced inositol depletion in rat brain after chronic treatment is restricted to the hypothalamus.
Molecular psychiatry 1997;2(5):407-12.
1997: S Bott; U Bott; Mathias Berger; Ingrid Mühlhauser
Intensified insulin therapy and the risk of severe hypoglycaemia.
Diabetologia 1997;40(8):926-32.
1997: Peter T Sawicki; T Heise; Mathias Berger
Antihypertensive treatment and mortality in diabetic patients. What is the evidence?
Diabetologia 1997;40 Suppl 2():S134-7.
1997: Mathias Berger; Lutz Heinemann
Are presently available insulin analogues clinically beneficial?
Diabetologia 1997;40 Suppl 2():S91-6.
1997: Andrea Icks; Christoph Trautner; Burkhard Haastert; Mathias Berger; Guido Giani
Blindness due to diabetes: population-based age- and sex-specific incidence rates.
Diabetic medicine : a journal of the British Diabetic Association 1997;14(7):571-5.
1997: Christoph Trautner; Andrea Icks; Burkhard Haastert; F Plum; Mathias Berger
Incidence of blindness in relation to diabetes. A population-based study.
Diabetes care 1997;20(7):1147-53.
1997: Mathias Berger; Vollmann Jochen; Fritz Hohagen; A König; H Lohner; Ulrich Voderholzer; Dieter Riemann
Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patients.
The American journal of psychiatry 1997;154(6):870-2.
1997: Manfred Wolfersdorf; Rolf-Dieter Stieglitz; R Metzger; A Ruppe; S Stabenow; C Hornstein; F Keller; G Schell; Mathias Berger
[Quality assurance in inpatient treatment of depression. Aspects of quality monitoring and external quality assurance exemplified by a pilot project of inpatient treatment of depression].
Psychiatrische Praxis 1997;24(3):120-8.
1997: Jörg Walden; J von Wegerer; U Winter; Mathias Berger; Heinz Grunze
Effects of kawain and dihydromethysticin on field potential changes in the hippocampus.
Progress in neuro-psychopharmacology & biological psychiatry 1997;21(4):697-706.
1997: J von Wegerer; Bernd Hesslinger; Mathias Berger; Jörg Walden
A calcium antagonistic effect of the new antiepileptic drug lamotrigine.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1997;7(2):77-81.
1997: L Baving; H Maes; Martin Bohus; Stefanie Lis; Stephan Krieger; Hans M Olbrich; Mathias Berger
Can negative self-schemes in depressives be altered through sleep deprivation?
Journal of affective disorders 1997;42(2-3):93-101.
1997: Ulrich Frommberger; J Bauer; P Haselbauer; A Fräulin; Dieter Riemann; Mathias Berger
Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission.
European archives of psychiatry and clinical neuroscience 1997;247(4):228-33.
1997: Heidemarie Hecht; Dietrich van Calker; G Spraul; Martin Bohus; H J Wark; Mathias Berger; Detlev von Zerssen
Premorbid personality in patients with uni- and bipolar affective disorders and controls: assessment by the Biographical Personality Interview (BPI).
European archives of psychiatry and clinical neuroscience 1997;247(1):23-30.
1996: Martin Bohus; U Förstner; C Kiefer; PJ Gebicke-Härter; J Timmer; G Spraul; H J Wark; Heidemarie Hecht; Mathias Berger; Dietrich van Calker
Increased sensitivity of the inositol-phospholipid system in neutrophils from patients with acute major depressive episodes.
Psychiatry research 1996;65(1):45-51.
1996: Klaus Lieb; Bernd L Fiebich; H Schaller; Mathias Berger; J Bauer
Interleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B.
Journal of neurochemistry 1996;67(5):2039-44.
1996: A Weyerbrock; J Timmer; Fritz Hohagen; Mathias Berger; J Bauer
Effects of light and chronotherapy on human circadian rhythms in delayed sleep phase syndrome: cytokines, cortisol, growth hormone, and the sleep-wake cycle.
Biological psychiatry 1996;40(8):794-7.
1996: N Rösler; Michael Hüll; Klaus Lieb; R Wolf; Mathias Berger; J Bauer
[Dementias--diagnosis, differential diagnosis and therapy].
Fortschritte der Medizin 1996;114(28):351-6.
1996: Christoph Trautner; Andrea Icks; Burkhard Haastert; F Plum; Mathias Berger; Guido Giani
Diabetes as a predictor of mortality in a cohort of blind subjects.
International journal of epidemiology 1996;25(5):1038-43.
1996: Bernd L Fiebich; Knut Biber; Klaus Lieb; Dietrich van Calker; Mathias Berger; J Bauer; Peter J Gebicke-Haerter
Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors.
Glia 1996;18(2):152-60.
1996: Knut Biber; Jörg Walden; PJ Gebicke-Härter; Mathias Berger; Dietrich van Calker
Carbamazepine inhibits the potentiation by adenosine analogues of agonist induced inositolphosphate formation in hippocampal astrocyte cultures.
Biological psychiatry 1996;40(7):563-7.
1996: Klaus Lieb; G Dammann; Mathias Berger; J Bauer
[Chronic fatigue syndrome. Definition, diagnostic measures and therapeutic possibilities].
Der Nervenarzt 1996;67(9):711-20.
1996: Jörg Walden; Bernd Hesslinger; Dietrich van Calker; Mathias Berger
Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder.
Pharmacopsychiatry 1996;29(5):193-5.
1996: Christoph Trautner; Burkhard Haastert; Guido Giani; Mathias Berger
Incidence of lower limb amputations and diabetes.
Diabetes care 1996;19(9):1006-9.
1996: R Vauth; Fritz Hohagen; D von Calker; Mathias Berger
[Organization of practice oriented knowledge structures by the "cognitive apprenticeship" method].
Zeitschrift für ärztliche Fortbildung 1996;90(5):459-64.
1996: Martin Härter; R Vauth; B Tausch; Mathias Berger
[Goals, content and evaluation of training seminars for quality circle moderators].
Zeitschrift für ärztliche Fortbildung 1996;90(5):394-9.
1996: Lutz Heinemann; Tim Heise; L C Wahl; M E Trautmann; J Ampudia; Achim Starke; Mathias Berger
Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.
Diabetic medicine : a journal of the British Diabetic Association 1996;13(7):625-9.
1996: Mathias Berger
To bridge science and patient care in diabetes.
Diabetologia 1996;39(7):749-57.
1996: Peter J Gebicke-Haerter; F Christoffel; J Timmer; H Northoff; Mathias Berger; Dietrich van Calker
Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation.
Neurochemistry international 1996;29(1):37-42.
1996: Klaus Lieb; Bernd L Fiebich; M Busse-Grawitz; Michael Hüll; Mathias Berger; J Bauer
Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1 beta and interleukin-6 in human monocytes: a re-examination.
Journal of neuroimmunology 1996;67(2):77-81.
1996: Ingrid Mühlhauser; R Bender; U Bott; V Jörgens; M Grüsser; W Wagener; H Overmann; Mathias Berger
Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1996;13(6):536-43.
1996: Michael Hüll; S Strauss; Mathias Berger; Benedikt Volk; J Bauer
The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease.
Behavioural brain research 1996;78(1):37-41.
1996: Ulrich Voderholzer; Dieter Riemann; Fritz Hohagen; A König; Mathias Berger
[Sleep and depression].
Der Internist 1996;37(5):483-9.
1996: Bernd Hesslinger; H Riedel; B Hellwig; Jörg Walden; Mathias Berger
[Phase prevention in bipolar affective disorder with nimodipine. A case report].
Der Nervenarzt 1996;67(5):394-6.
1996: Dieter Riemann; Stefanie Lis; Rosemarie Fritsch; T Meier; Stephan Krieger; Fritz Hohagen; Mathias Berger
Effect of tetrahydroaminoacridine on sleep in healthy subjects.
Biological psychiatry 1996;39(9):796-802.
1996: Bernd L Fiebich; Klaus Lieb; Michael Hüll; Mathias Berger; J Bauer
Effects of NSAIDs on IL-1 beta-induced IL-6 mRNA and protein synthesis in human astrocytoma cells.
Neuroreport 1996;7(6):1209-13.
1996: Dieter Riemann; Fritz Hohagen; A König; B Schwarz; J Gomille; Ulrich Voderholzer; Mathias Berger
Advanced vs. normal sleep timing: effects on depressed mood after response to sleep deprivation in patients with a major depressive disorder.
Journal of affective disorders 1996;37(2-3):121-8.
1996: Peter T Sawicki; Ingrid Mühlhauser; R Bender; W Pethke; Lutz Heinemann; Mathias Berger
Effects of smoking on blood pressure and proteinuria in patients with diabetic nephropathy.
Journal of internal medicine 1996;239(4):345-52.
1996: Klaus Lieb; Christian Kaltschmidt; barbara kaltschmidt; PA Baeuerle; Mathias Berger; J Bauer; Bernd L Fiebich
Interleukin-1 beta uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor alpha genes in the human astrocytoma cell line U373.
Journal of neurochemistry 1996;66(4):1496-503.
1996: Bernd L Fiebich; Knut Biber; K Gyufko; Mathias Berger; J Bauer; Dietrich van Calker
Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells.
Journal of neurochemistry 1996;66(4):1426-31.
1996: Y Patishi; B Lubrich; Mathias Berger; Ora Kofman; Dietrich van Calker; Robert H Belmaker
Differential uptake of myo-inositol in vivo into rat brain areas.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1996;6(1):73-5.
1996: Bernd Hesslinger; B Hellwig; U Sester; Jörg Walden; Mathias Berger
An acute psychotic disorder caused by pefloxacin: a case report.
Progress in neuro-psychopharmacology & biological psychiatry 1996;20(2):343-7.
1996: I Mühlhauser; K Prange; Peter T Sawicki; R Bender; A Dworschak; W Schaden; Mathias Berger
Effects of dietary sodium on blood pressure in IDDM patients with nephropathy.
Diabetologia 1996;39(2):212-9.
1996: Michael Hüll; Mathias Berger; Benedikt Volk; J Bauer
Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques.
Annals of the New York Academy of Sciences 1996;777():205-12.
1996: Mathias Berger; M Gastpar
Trimipramine: a challenge to current concepts on antidepressives.
European archives of psychiatry and clinical neuroscience 1996;246(5):235-9.
1996: Michael Hüll; S Strauss; Mathias Berger; Benedikt Volk; J Bauer
Inflammatory mechanisms in Alzheimer's disease.
European archives of psychiatry and clinical neuroscience 1996;246(3):124-8.
1996: Peter T Sawicki; R Dähne; R Bender; Mathias Berger
Prolonged QT interval as a predictor of mortality in diabetic nephropathy.
Diabetologia 1996;39(1):77-81.
1995: Bernd L Fiebich; Klaus Lieb; Mathias Berger; J Bauer
Stimulation of the sphingomyelin pathway induces interleukin-6 gene expression in human astrocytoma cells.
Journal of neuroimmunology 1995;63(2):207-11.
1995: R Kimmerle; Lutz Heinemann; Mathias Berger
Intrauterine devices are safe and effective contraceptives for type I diabetic women.
Diabetes care 1995;18(11):1506-7.
1995: Peter T Sawicki; Ingrid Mühlhauser; U Didjurgeit; M Reimann; R Bender; Mathias Berger
Mortality and morbidity in treated hypertensive type 2 diabetic patients with micro- or macroproteinuria.
Diabetic medicine : a journal of the British Diabetic Association 1995;12(10):893-8.
1995: Peter T Sawicki; Ingrid Mühlhauser; U Didjurgeit; Mathias Berger
Effects of intensification of antihypertensive care in diabetic nephropathy.
Journal of diabetes and its complications 1995;9(4):315-7.
1995: H Gann; Dieter Riemann; S Stoll; Mathias Berger; W E Müller
Growth hormone response to growth hormone-releasing hormone and clonidine in depression.
Biological psychiatry 1995;38(5):325-9.
1995: Peter T Sawicki; Ingrid Mühlhauser; U Didjurgeit; A Baumgartner; R Bender; Mathias Berger
Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy.
Journal of hypertension 1995;13(8):933-8.
1995: B Tausch; Martin Härter; W Niebling; G Dieter; Mathias Berger
[Implementation and evaluation of quality circles in general practice].
Zeitschrift für ärztliche Fortbildung 1995;89(4):402-5.
1995: Dieter Riemann; Vollmann Jochen; Fritz Hohagen; H Lohner; A König; C Faller; N Edali; Mathias Berger
[Treatment of depression with sleep deprivation and sleep phase advancement].
Fortschritte der Neurologie-Psychiatrie 1995;63(7):270-6.
1995: Ingrid Mühlhauser; U Bott; H Overmann; W Wagener; R Bender; V Jörgens; Mathias Berger
Liberalized diet in patients with type 1 diabetes.
Journal of internal medicine 1995;237(6):591-7.
1995: J Bauer; M Hüll; Mathias Berger
[Pathogenetic factors of Alzheimer disease].
Zeitschrift für Gerontologie und Geriatrie 1995;28(3):155.
1995: W Trabert; Fritz Hohagen; G Winkelmann; Mathias Berger
A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder.
Pharmacopsychiatry 1995;28(3):95-7.
1995: H Gann; Dieter Riemann; S Stoll; Mathias Berger; W E Müller
Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
Pharmacopsychiatry 1995;28(3):80-3.
1995: Mathias Berger; Ingrid Mühlhauser
Implementation of intensified insulin therapy: a European perspective.
Diabetic medicine : a journal of the British Diabetic Association 1995;12(3):201-8.
1995: U Frommberger; J Angenendt; Mathias Berger
[Treatment of panic disorders and agoraphobia. Psychotherapy, psychopharmacotherapy and their combination].
Der Nervenarzt 1995;66(3):173-86.
1995: Jörg Walden; J von Wegerer; I Roed; Mathias Berger
Effects of the serotonin-1A agonists buspirone and ipsapirone on field potentials in the hippocampus slice: comparison with carbamzepine and verapamil.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5(1):57-61.
1995: R Kimmerle; R P Zass; S Cupisti; Thierry Somville; R Bender; B Pawlowski; Mathias Berger
Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child.
Diabetologia 1995;38(2):227-35.
1995: Ulrich Voderholzer; Anna Wirz-Justice; L Demisch; Mathias Berger; Dieter Riemann
[Case report: treatment of a patient with sleep phase advance disorder with phototherapy].
Wiener medizinische Wochenschrift (1946) 1995;145(17-18):470-2.
1995: Mathias Berger; Fritz Hohagen; A König; Vollmann Jochen; H Lohner; C Faller; N Edali; Dieter Riemann
[Chronotherapeutic approaches in depressive disorders].
Wiener medizinische Wochenschrift (1946) 1995;145(17-18):418-22.
1995: E Schramm; Fritz Hohagen; C Käppler; U Grasshoff; Mathias Berger
Mental comorbidity of chronic insomnia in general practice attenders using DSM-III-R.
Acta psychiatrica Scandinavica 1995;91(1):10-7.
1995: Michael Huell; S Strauss; Benedikt Volk; Mathias Berger; J Bauer
Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients.
Acta neuropathologica 1995;89(6):544-51.
1995: Jörg Walden; J Fritze; Dietrich van Calker; Mathias Berger; Heinz Grunze
A calcium antagonist for the treatment of depressive episodes: single case reports.
Journal of psychiatric research 1995;29(1):71-6.
1994: R Kimmerle; G Schmitt; Mathias Berger
[Contraception in patients with type I diabetes: a survey of 808 women of reproductive age].
Geburtshilfe und Frauenheilkunde 1994;54(12):691-6.
1994: Dieter Riemann; M Schnitzler; Fritz Hohagen; Mathias Berger
[Depression and sleep--the status of current research].
Fortschritte der Neurologie-Psychiatrie 1994;62(12):458-78.
1994: Fritz Hohagen; C Käppler; E Schramm; Dieter Riemann; S Weyerer; Mathias Berger
Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening--temporal stability of subtypes in a longitudinal study on general practice attenders.
Sleep 1994;17(6):551-4.
1994: Fritz Hohagen; C Käppler; E Schramm; K Rink; S Weyerer; Dieter Riemann; Mathias Berger
Prevalence of insomnia in elderly general practice attenders and the current treatment modalities.
Acta psychiatrica Scandinavica 1994;90(2):102-8.
1994: Fritz Hohagen; Stefanie Lis; Dieter Riemann; Stephan Krieger; C Meyer; R F Montero; Heinz Grunze; Mathias Berger
Influence of biperiden and bornaprine on sleep in healthy subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;11(1):29-32.
1994: F J Ampudia-Blasco; Lutz Heinemann; R Bender; A Schmidt; Tim Heise; Mathias Berger; Achim Starke
Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjects.
Diabetologia 1994;37(7):703-7.
1994: H Gann; Dieter Riemann; Fritz Hohagen; W E Müller; Mathias Berger
The influence of carbamazepine on sleep-EEG and the clonidine test in healthy subjects: results of a preliminary study.
Biological psychiatry 1994;35(11):893-6.
1994: U Bott; V Jörgens; M Grüsser; R Bender; Ingrid Mühlhauser; Mathias Berger
Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme.
Diabetic medicine : a journal of the British Diabetic Association 1994;11(4):362-71.
1994: Dieter Riemann; Fritz Hohagen; Stephan Krieger; H Gann; W E Müller; R Olbrich; H J Wark; Martin Bohus; H Löw; Mathias Berger
Cholinergic REM induction test: muscarinic supersensitivity underlies polysomnographic findings in both depression and schizophrenia.
Journal of psychiatric research 1994;28(3):195-210.
1994: Peter J Gebicke-Haerter; Kurt Appel; P Honegger; Mathias Berger
Changes of beta-amyloid precursor protein splice patterns in brain cell aggregate cultures.
Journal of neuroscience research 1994;38(1):32-40.
1994: G Sindelka; Lutz Heinemann; Mathias Berger; W Frenck; Ernst Chantelau
Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects.
Diabetologia 1994;37(4):377-80.
1994: Peter J Gebicke-Haerter; Kurt Appel; G D Taylor; A Schobert; I N Rich; Hinnak Northoff; Mathias Berger
Rat microglial interleukin-3.
Journal of neuroimmunology 1994;50(2):203-14.
1994: J Bauer; Fritz Hohagen; T Ebert; J Timmer; U Ganter; Stephan Krieger; Stefanie Lis; E Postler; Ulrich Voderholzer; Mathias Berger
Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle.
The Clinical investigator 1994;72(4):315.
1994: E G Starostina; M Antsiferov; G R Galstyan; Christoph Trautner; V Jörgens; U Bott; Ingrid Mühlhauser; Mathias Berger; I I Dedov
Effectiveness and cost-benefit analysis of intensive treatment and teaching programmes for type 1 (insulin-dependent) diabetes mellitus in Moscow--blood glucose versus urine glucose self-monitoring.
Diabetologia 1994;37(2):170-6.
1994: Peter T Sawicki; U Didjurgeit; Ingrid Mühlhauser; R Bender; Lutz Heinemann; Mathias Berger
Smoking is associated with progression of diabetic nephropathy.
Diabetes care 1994;17(2):126-31.
1994: Dieter Riemann; Fritz Hohagen; M Bahro; Mathias Berger
Sleep in depression: the influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86.
European archives of psychiatry and clinical neuroscience 1994;243(5):279-90.
1994: Fritz Hohagen; Stefanie Lis; Stephan Krieger; G Winkelmann; Dieter Riemann; Rosemarie Fritsch; E Rey; J Aldenhoff; Mathias Berger
Sleep EEG of patients with obsessive-compulsive disorder.
European archives of psychiatry and clinical neuroscience 1994;243(5):273-8.
1994: U Förstner; Martin Bohus; PJ Gebicke-Härter; B Baumer; Mathias Berger; Dietrich van Calker
Decreased agonist-stimulated Ca2+ response in neutrophils from patients under chronic lithium therapy.
European archives of psychiatry and clinical neuroscience 1994;243(5):240-3.
1994: R Kimmerle; T Wimmer; M Markus; Lutz Heinemann; Ernst Günter Vester; Mathias Berger
[Risk factors in hyperlipidemic patients with coronary heart disease one year after PTCA].
Zeitschrift für Kardiologie 1994;83(1):9-15.
1994: Fritz Hohagen; R F Montero; E Weiss; Stefanie Lis; E Schönbrunn; H Dressing; Dieter Riemann; Mathias Berger
Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics?
European archives of psychiatry and clinical neuroscience 1994;244(2):65-72.
1994: Dieter Riemann; Fritz Hohagen; M Bahro; Stefanie Lis; G Stadmüller; H Gann; Mathias Berger
Cholinergic neurotransmission, REM sleep and depression.
Journal of psychosomatic research 1994;38 Suppl 1():15-25.
1993: Peter T Sawicki; Ingrid Mühlhauser; U Didjurgeit; Mathias Berger
Improvement of hypertension care by a structured treatment and teaching programme.
Journal of human hypertension 1993;7(6):571-3.
1993: Fritz Hohagen; Dieter Riemann; R Spiegel; M Holzhauer; Mathias Berger
Influence of the cholinergic agonist SDZ 210-086 on sleep in healthy subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;9(3):225-32.
1993: Dieter Riemann; M Wiegand; Christoph J Lauer; Mathias Berger
Naps after total sleep deprivation in depressed patients: are they depressiogenic?
Psychiatry research 1993;49(2):109-20.
1993: Christoph Trautner; Bernd Richter; Mathias Berger
Cost-effectiveness of a structured treatment and teaching programme on asthma.
The European respiratory journal 1993;6(10):1485-91.
1993: Peter T Sawicki; U Didjurgeit; Ingrid Mühlhauser; Mathias Berger
Behaviour therapy versus doctor's anti-smoking advice in diabetic patients.
Journal of internal medicine 1993;234(4):407-9.
1993: M Bahro; Dieter Riemann; G Stadtmüller; Mathias Berger; Wagner F Gattaz
REM sleep parameters in the discrimination of probable Alzheimer's disease from old-age depression.
Biological psychiatry 1993;34(7):482-6.
1993: R Kimmerle; R Weiss; Mathias Berger; K H Kurz
Effectiveness, safety, and acceptability of a copper intrauterine device (CU Safe 300) in type I diabetic women.
Diabetes care 1993;16(9):1227-30.
1993: H U Müller; Dieter Riemann; Mathias Berger; W E Müller
The influence of total sleep deprivation on urinary excretion of catecholamine metabolites in major depression.
Acta psychiatrica Scandinavica 1993;88(1):16-20.
1993: Mathias Berger
[Cholesterol non-consensus in primary prevention of coronary heart disease. Methodologic problems in the interpretation of epidemiologic studies].
Zeitschrift für Kardiologie 1993;82(7):399-405.
1993: E Schramm; Fritz Hohagen; U Grasshoff; Dieter Riemann; G Hajak; H G Weess; Mathias Berger
Test-retest reliability and validity of the Structured Interview for Sleep Disorders According to DSM-III-R.
The American journal of psychiatry 1993;150(6):867-72.
1993: J Bauer; U Ganter; J Abel; S Strauss; U Jonas; R Weiss; Peter J Gebicke-Haerter; B Volk; Mathias Berger
Effects of interleukin-1 and interleukin-6 on metallothionein and amyloid precursor protein expression in human neuroblastoma cells. Evidence that interleukin-6 possibly acts via a receptor different from the 80-kDa interleukin-6 receptor.
Journal of neuroimmunology 1993;45(1-2):163-73.
1993: H Gann; Dieter Riemann; Fritz Hohagen; Ludwig G. Strauss; H Dressing; W E Müller; Mathias Berger
48-hour rapid cycling: results of psychopathometric, polysomnographic, PET imaging and neuro-endocrine longitudinal investigations in a single case.
Journal of affective disorders 1993;28(2):133-40.
1993: Ingrid Mühlhauser; Mathias Berger
Diabetes education and insulin therapy: when will they ever learn?
Journal of internal medicine 1993;233(4):321-6.
1993: M Wiegand; Dieter Riemann; Wolfgang Schreiber; Christoph J Lauer; Mathias Berger
Effect of morning and afternoon naps on mood after total sleep deprivation in patients with major depression.
Biological psychiatry 1993;33(6):467-76.
1993: V Jörgens; M Grüsser; U Bott; Ingrid Mühlhauser; Mathias Berger
Effective and safe translation of intensified insulin therapy to general internal medicine departments.
Diabetologia 1993;36(2):99-105.
1993: Ingrid Mühlhauser; Peter T Sawicki; U Didjurgeit; V Jörgens; H J Trampisch; Mathias Berger
Evaluation of a structured treatment and teaching programme on hypertension in general practice.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1993;15(1):125-42.
1993: Vollmann Jochen; Mathias Berger
Sleep deprivation with consecutive sleep-phase advance therapy in patients with major depression: a pilot study.
Biological psychiatry 1993;33(1):54-7.
1993: T Schubert; L Stoll; P Fleckenstein; Dieter Riemann; Mathias Berger; W E Müller
Effects of single and repeated clonidine administration on the properties of central and peripheral alpha 2-adrenoceptors in man.
Pharmacology 1993;46(2):82-90.
1993: Fritz Hohagen; K Rink; C Käppler; E Schramm; Dieter Riemann; S Weyerer; Mathias Berger
Prevalence and treatment of insomnia in general practice. A longitudinal study.
European archives of psychiatry and clinical neuroscience 1993;242(6):329-36.
1993: Fritz Hohagen; J Timmer; A Weyerbrock; Rosemarie Fritsch; U Ganter; Stephan Krieger; Mathias Berger; J Bauer
Cytokine production during sleep and wakefulness and its relationship to cortisol in healthy humans.
Neuropsychobiology 1993;28(1-2):9-16.
1993: Dietrich van Calker; U Förstner; Martin Bohus; PJ Gebicke-Härter; Heidemarie Hecht; H J Wark; Mathias Berger
Increased sensitivity to agonist stimulation of the Ca2+ response in neutrophils of manic-depressive patients: effect of lithium therapy.
Neuropsychobiology 1993;27(3):180-3.
1993: Dieter Riemann; H Gann; Fritz Hohagen; M Bahro; W E Müller; Mathias Berger
The effect of carbamazepine on endocrine and sleep EEG variables in a patient with 48-hour rapid cycling, and healthy controls.
Neuropsychobiology 1993;27(3):163-70.
1992: Mathias Berger
Risk of obesity in type II diabetes mellitus.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1992;16 Suppl 4():S29-33.
1992: Jörg Walden; Heinz Grunze; H Olbrich; Mathias Berger
[Importance of calcium ions and calcium antagonists in affective psychoses].
Fortschritte der Neurologie-Psychiatrie 1992;60(12):471-6.
1992: H Gann; Dieter Riemann; Fritz Hohagen; H Dressing; W E Müller; Mathias Berger
The sleep structure of patients with anxiety disorders in comparison to that of healthy controls and depressive patients under baseline conditions and after cholinergic stimulation.
Journal of affective disorders 1992;26(3):179-89.
1992: Achim Starke; A Frilling; H Becker; Hans-Dietrich Röher; Mathias Berger
Are CAT-scans necessary for preoperative localization of insulinomas?
The European journal of medicine 1992;1(7):411-3.
1992: Peter T Sawicki; T Baba; Mathias Berger; Achim Starke
Normal blood pressure in patients with insulinoma despite hyperinsulinemia and insulin resistance.
Journal of the American Society of Nephrology : JASN 1992;3(4 Suppl):S64-8.
1992: H Dressing; Dieter Riemann; H Gann; Mathias Berger
The effects of biperiden on nap sleep after sleep deprivation in depressed patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1992;7(1):1-5.
1992: R Kimmerle; Lutz Heinemann; A Delecki; Mathias Berger
Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women.
Diabetes care 1992;15(8):1034-7.
1992: Peter T Sawicki; Lutz Heinemann; Achim Starke; Mathias Berger
Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma.
Diabetologia 1992;35(7):649-52.
1992: Dieter Riemann; Mathias Berger
Sleep, age, depression and the cholinergic REM induction test with RS 86.
Progress in neuro-psychopharmacology & biological psychiatry 1992;16(3):311-6.
1992: Ingrid Mühlhauser; M Sulzer; Mathias Berger
Quality assessment of diabetes care according to the recommendations of the St. Vincent Declaration: a population-based study in a rural area of Austria.
Diabetologia 1992;35(5):429-35.
1992: Dieter Riemann; Fritz Hohagen; Rosemarie Fritsch; Stephan Krieger; H Gann; H Dressing; W Muller; Mathias Berger
Cholinergic and noradrenergic neurotransmission: impact on REM sleep regulation in healthy subjects and depressed patients.
Acta psychiatrica Belgica 1992;92(3):151-71.
1992: Lutz Heinemann; Achim Starke; A Hohmann; Mathias Berger
Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal.
Hormone and metabolic research. Supplement series 1992;26():137-9.
1991: Dieter Riemann; Fritz Hohagen; P Fleckenstein; Michael Schredl; Mathias Berger
The cholinergic REM induction test with RS 86 after scopolamine pretreatment in healthy subjects.
Psychiatry research 1991;38(3):247-60.
1991: Ingrid Mühlhauser; Lutz Heinemann; J Karinganamattom; W Schuwirth; Mathias Berger
Accuracy of blood glucose self monitoring in elderly insulin treated diabetic patients.
Diabète & métabolisme 1991;17(5):476-82.
1991: Ingrid Mühlhauser; Lutz Heinemann; Ellen Fritsche; K von Lennep; Mathias Berger
Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparations.
Diabetes care 1991;14(8):745-9.
1991: Ingrid Mühlhauser; Bernd Richter; D Kraut; G Weske; Heinrich Worth; Mathias Berger
Evaluation of a structured treatment and teaching programme on asthma.
Journal of internal medicine 1991;230(2):157-64.
1991: Dieter Riemann; H Gann; P Fleckenstein; Fritz Hohagen; R Olbrich; Mathias Berger
Effect of RS 86 on REM latency in schizophrenia.
Psychiatry research 1991;38(1):89-92.
1991: Peter T Sawicki; S Kaiser; Lutz Heinemann; H Frenzel; Mathias Berger
Prevalence of renal artery stenosis in diabetes mellitus--an autopsy study.
Journal of internal medicine 1991;229(6):489-92.
1991: Christoph J Lauer; Dieter Riemann; M Wiegand; Mathias Berger
From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers.
Biological psychiatry 1991;29(10):979-93.
1991: M Wiegand; Wolfgang Schreiber; Christoph J Lauer; Mathias Berger
The action of clenbuterol on sleep and symptomatology in depressives.
Pharmacopsychiatry 1991;24(3):89-92.
1991: Ingrid Mühlhauser; G Toth; Peter T Sawicki; Mathias Berger
Severe hypoglycemia in type I diabetic patients with impaired kidney function.
Diabetes care 1991;14(4):344-6.
1991: Dieter Riemann; M Wiegand; Mathias Berger
Are there predictors for sleep deprivation response in depressed patients?
Biological psychiatry 1991;29(7):707-10.
1991: Peter T Sawicki; L Karschny; V Stolpe; E Wolf; Mathias Berger
Color discrimination and accuracy of blood glucose self-monitoring in type I diabetic patients.
Diabetes care 1991;14(2):135-7.
1991: B Dippel; J Kemper; Mathias Berger
Folie à six: a case report on induced psychotic disorder.
Acta psychiatrica Scandinavica 1991;83(2):137-41.
1991: H Dressing; Mathias Berger
[Post-traumatic stress disorders. On the development of the current disease concept].
Der Nervenarzt 1991;62(1):16-26.
1991: Mathias Berger; Dieter Riemann; C Krieg
Cholinergic drugs as diagnostic and therapeutic tools in affective disorders.
Acta psychiatrica Scandinavica. Supplementum 1991;366():52-60.
1990: Dieter Riemann; S Velthaus; S Laubenthal; W E Müller; Mathias Berger
REM-suppressing effects of amitriptyline and amitriptyline-N-oxide after acute medication in healthy volunteers: results of two uncontrolled pilot trials.
Pharmacopsychiatry 1990;23(6):253-8.
1990: G E Sonnenberg; F W Kemmer; Mathias Berger
Exercise in type 1 (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion. Prevention of exercise induced hypoglycaemia.
Diabetologia 1990;33(11):696-703.
1990: Peter T Sawicki; U Didjurgeit; Ingrid Mühlhauser; Lutz Heinemann; Mathias Berger
Near-normotension and near-normoglycemia in blind type I diabetic patients with overt diabetic nephropathy.
The Journal of diabetic complications 1990;4(4):179-83.
1990: Dieter Riemann; H Löw; Michael Schredl; M Wiegand; B Dippel; Mathias Berger
Investigations of morning and laboratory dream recall and content in depressive patients during baseline conditions and under antidepressive treatment with trimipramine.
Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Université d'Ottawa 1990;15(2):93-9.
1990: Lutz Heinemann; Achim Starke; L Heding; I Jensen; Mathias Berger
Action profiles of fast onset insulin analogues.
Diabetologia 1990;33(6):384-6.
1990: E Schönbrunn; Dieter Riemann; Fritz Hohagen; Mathias Berger
[Restless legs and sleep apnea syndrome--random coincidence or causal relation?].
Der Nervenarzt 1990;61(5):306-11.
1990: Christoph J Lauer; Jürgen-Christian Krieg; Dieter Riemann; J Zulley; Mathias Berger
A polysomnographic study in young psychiatric inpatients: major depression, anorexia nervosa, bulimia nervosa.
Journal of affective disorders 1990;18(4):235-45.
1990: Peter T Sawicki; Ingrid Mühlhauser; T Baba; Mathias Berger
Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?
Diabetologia 1990;33(2):121-4.
1990: Dieter Riemann; Mathias Berger
The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder.
Acta psychiatrica Scandinavica 1990;81(1):24-31.
1989: Lutz Heinemann; G E Sonnenberg; A Hohmann; A Ritzenhoff; Mathias Berger; J Benn; P Sönksen; D Kelley; J Gerich; Thomas Aoki
Pulsatile insulin infusion and glucose-homeostasis in well-controlled type 1 (insulin-dependent) diabetic patients.
Journal of internal medicine 1989;226(5):325-30.
1989: M Spraul; A Streeck; M Nieradzik; Mathias Berger
Uniform elimination pattern for glibenclamide in healthy Caucasian males.
Arzneimittel-Forschung 1989;39(11):1449-50.
1989: Christoph J Lauer; J C Krieg; J Zulley; Dieter Riemann; Mathias Berger
[Sleep in anorexia nervosa, bulimia nervosa and depressive diseases: a polysomnographic comparative study].
Fortschritte der Neurologie-Psychiatrie 1989;57(10):403-10.
1989: G Mauricio-Leguizamo; Lutz Heinemann; Rüdiger E Scharf; Mathias Berger
Effect of 8 hours of hyperinsulinaemia on haemostatic parameters in healthy man.
Diabetologia 1989;32(8):606-10.
1989: Peter T Sawicki; Lutz Heinemann; Mathias Berger
Comparison of methods for determination of microalbuminuria in diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1989;6(5):412-5.
1989: Ernst Chantelau; M Spraul; Ingrid Mühlhauser; R Gause; Mathias Berger
Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience.
Diabetologia 1989;32(7):421-6.
1989: Dieter Riemann; Mathias Berger
EEG sleep in depression and in remission and the REM sleep response to the cholinergic agonist RS 86.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1989;2(2):145-52.
1989: Mathias Berger; Dieter Riemann; D Höchli; R Spiegel
The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression?
Archives of general psychiatry 1989;46(5):421-8.
1989: Achim Starke; Lutz Heinemann; A Hohmann; Mathias Berger
[Action profile of human ultralente insulin compared with human NPH-insulin].
Deutsche medizinische Wochenschrift (1946) 1989;114(16):618-22.
1989: Achim Starke; Lutz Heinemann; A Hohmann; Mathias Berger
The action profiles of human NPH insulin preparations.
Diabetic medicine : a journal of the British Diabetic Association 1989;6(3):239-44.
1989: Ernst Chantelau; M Zwecker; H Weiss; G Kluxen; Mathias Berger
Fundus polaroid screening for diabetic retinopathy. Is one print per patient enough?
Diabetes care 1989;12(3):223-6.
1989: Christoph J Lauer; W Schreiber; Mathias Berger; K M Pirke; Florian Holsboer; J C Krieg
The effect of neuroendocrine secretion on brain morphology and EEG sleep in patients with eating disorders.
European archives of psychiatry and neurological sciences 1989;238(4):208-12.
1989: M Wiegand; Mathias Berger
Action of trimipramine on sleep and pituitary hormone secretion.
Drugs 1989;38 Suppl 1():35-42; discussion 49-50.
1988: P Kronsbein; V Jörgens; Ingrid Mühlhauser; V Scholz; A Venhaus; Mathias Berger
Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes.
Lancet 1988;2(8625):1407-11.
1988: Christoph J Lauer; J Zulley; J C Krieg; Dieter Riemann; Mathias Berger
EEG sleep and the cholinergic REM induction test in anorexic and bulimic patients.
Psychiatry research 1988;26(2):171-81.
1988: M Spraul; Ernst Chantelau; J Koumoulidou; Mathias Berger
Subcutaneous or nonsubcutaneous injection of insulin.
Diabetes care 1988;11(9):733-6.
1988: Peter T Sawicki; Lutz Heinemann; Klaus Rave; A Hohmann; Mathias Berger
Atrial natriuretic factor in various stages of diabetic nephropathy.
The Journal of diabetic complications 1988;2(4):207-9.
1988: Ingrid Mühlhauser; Peter T Sawicki; U Didjurgeit; V Jörgens; Mathias Berger
Uncontrolled hypertension in type 1 diabetes: assessment of patients' desires about treatment and improvement of blood pressure control by a structured treatment and teaching programme.
Diabetic medicine : a journal of the British Diabetic Association 1988;5(7):693-8.
1988: M Spraul; Ernst Chantelau; A M Schönbach; Mathias Berger
Glycemic effects of beer in IDDM patients. Studies with constant insulin delivery.
Diabetes care 1988;11(8):659-61.
1988: B Dippel; Dieter Riemann; K Majer-Trendel; Mathias Berger
[Manifest dream content of anorexia and bulimia patients--an intermediate report].
Psychotherapie, Psychosomatik, medizinische Psychologie 1988;38(6):199-204.
1988: Ernst Chantelau; H Weiss; U Weber; G E Sonnenberg; Mathias Berger
Four-year follow-up of retinal status and glycosylated haemoglobin in patients with insulin-dependent diabetes mellitus.
Diabète & métabolisme 1988;14(3):259-63.
1988: Dieter Riemann; D Joy; D Höchli; Christoph J Lauer; J Zulley; Mathias Berger
Influence of the cholinergic agonist RS 86 on normal sleep: sex and age effects.
Psychiatry research 1988;24(2):137-47.
1988: D Kelley; Asimina Mitrakou; Harold Michael Marsh; F Schwenk; J Benn; G Sonnenberg; M Arcangeli; Thomas Aoki; J Sorensen; Mathias Berger
Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load.
The Journal of clinical investigation 1988;81(5):1563-71.
1988: S Bossert; E Schnabel; Jürgen-Christian Krieg; Mathias Berger
Modifications and problems of behavioural inpatient management of anorexia nervosa: a "patient-suited" approach?
Acta psychiatrica Scandinavica 1988;77(1):105-10.
1988: S Bossert; Mathias Berger; Jürgen-Christian Krieg; Wolfgang Schreiber; M Junker; Detlev von Zerssen
Cortisol response to various stressful situations: relationship to personality variables and coping styles.
Neuropsychobiology 1988;20(1):36-42.
1988: M Pycior; F W Kemmer; Mathias Berger
Hypoglycemic effect of subcutaneously injected biosynthetic human proinsulin in healthy man.
Hormone and metabolic research. Supplement series 1988;18():22-4.
1988: Mathias Berger; C Krieg; S Bossert; W Schreiber; D von Zerssen
Past and present strategies of research on the HPA-axis in psychiatry.
Acta psychiatrica Scandinavica. Supplementum 1988;341():112-25.
1988: Peter T Sawicki; Lutz Heinemann; Klaus Rave; Mathias Berger
[Atrial natriuretic factor in patients with type 1 diabetes mellitus in various stages of diabetic nephropathy].
Zeitschrift für Kardiologie 1988;77 Suppl 2():111-3.
1988: Wolfgang Schreiber; Jürgen-Christian Krieg; S Bossert; M Junker; R Rauschhuber; Günter K Stalla; O A Müller; Mathias Berger
Methodological aspects of hCRF-stimulated ACTH and cortisol secretion in healthy subjects.
Psychoneuroendocrinology 1988;13(6):487-95.
1987: Mathias Berger; S Bossert; Jürgen-Christian Krieg; Gerhard Dirlich; W Ettmeier; Wolfgang Schreiber; Detlev von Zerssen
Interindividual differences in the susceptibility of the cortisol system: an important factor for the degree of hypercortisolism in stress situations?
Biological psychiatry 1987;22(11):1327-39.
1987: Jürgen-Christian Krieg; Mathias Berger
REM sleep and cortisol response to the cholinergic challenge with RS 86 in normals and depressives.
Acta psychiatrica Scandinavica 1987;76(5):600-2.
1987: Mathias Berger
Human insulin: much ado about hypoglycaemia (un)awareness.
Diabetologia 1987;30(11):829-33.
1987: F W Kemmer; M Tacken; Mathias Berger
Mechanism of exercise-induced hypoglycemia during sulfonylurea treatment.
Diabetes 1987;36(10):1178-82.
1987: S Bossert; E Schnabel; Jürgen-Christian Krieg; P Molitor; J Kemper; Mathias Berger
[Concept of integrative inpatient-ambulatory therapy in patients with anorexia nervosa: a revised therapeutic approach].
Psychotherapie, Psychosomatik, medizinische Psychologie 1987;37(9-10):331-6.
1987: Ingrid Mühlhauser; I Bruckner; Mathias Berger; D Cheţa; V Jörgens; C Ionescu-Tîrgovişte; V Scholz; I Mincu
Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study.
Diabetologia 1987;30(9):681-90.
1987: Jürgen-Christian Krieg; S Bossert; Karl-Martin Pirke; Detlev von Zerssen; Mathias Berger
The influence of the muscarinic agonist RS 86 on the cortisol system.
Biological psychiatry 1987;22(5):573-82.
1987: M Wiegand; Mathias Berger; J Zulley; Christoph J Lauer; D von Zerssen
The influence of daytime naps on the therapeutic effect of sleep deprivation.
Biological psychiatry 1987;22(3):389-92.
1987: D von Zerssen; Mathias Berger; P Doerr
Neuroendocrinological studies on depression with special reference to research at the Max-Planck-Institute of Psychiatry.
Pharmacopsychiatry 1987;20(1):8-22.
1987: B Dippel; Christoph J Lauer; Dieter Riemann; K Majer-Trendel; Jürgen-Christian Krieg; Mathias Berger
Sleep and dreams in eating disorders.
Psychotherapy and psychosomatics 1987;48(1-4):165-9.
1986: D Höchli; Dieter Riemann; J Zulley; Mathias Berger
Initial REM sleep suppression by clomipramine: a prognostic tool for treatment response in patients with a major depressive disorder.
Biological psychiatry 1986;21(12):1217-20.
1986: D Höchli; Dieter Riemann; J Zulley; Mathias Berger
Is there a relationship between response to total sleep deprivation and efficacy of clomipramine treatment in depressed patients?
Acta psychiatrica Scandinavica 1986;74(2):190-2.
1986: Ingrid Mühlhauser; A B Klemm; B Boor; V Scholz; Mathias Berger
[Length of stay and length of work incapacity in patients with Type I diabetes. Effects of a diabetes treatment and education program].
Deutsche medizinische Wochenschrift (1946) 1986;111(22):854-7.
1985: Mathias Berger; D Höchli; J Zulley; Christoph J Lauer; D von Zerssen
Cholinomimetic drug RS 86, REM sleep, and depression.
Lancet 1985;1(8442):1385-6.
1985: Ingrid Mühlhauser; Mathias Berger; G Sonnenberg; J Koch; V Jörgens; G Schernthaner; V Scholz; D Pädagogin
Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus.
Diabetes care 1985;8(3):268-73.
1985: Mathias Berger; K M Pirke; C J Krieg; Detlev von Zerssen; O A Muller; G K Stalla
ACTH and cortisol levels in healthy probands and psychiatric patients following the dexamethasone suppression test.
The American journal of psychiatry 1985;142(2):268-9.
1984: Mathias Berger; P Doerr; Detlev von Zerssen
Physostigmine's influence on DST results.
The American journal of psychiatry 1984;141(3):469-70.
1984: V Scholz; V Jorgens; Mathias Berger; P Konsbein; I Muhlhauser; L Hornke; B Willms
Evaluation of a postgraduate course for diabetes educators.
The Diabetes educator 1984;10 SPEC NO():80-4.
1983: Ingrid Mühlhauser; V Jörgens; Mathias Berger; W Graninger; W Gürtler; L Hornke; A Kunz; G Schernthaner; V Scholz; H E Voss
Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months.
Diabetologia 1983;25(6):470-6.
1983: Mathias Berger; R Lund; T Bronisch; Detlev von Zerssen
REM latency in neurotic and endogenous depression and the cholinergic REM induction test.
Psychiatry research 1983;10(2):113-23.
1983: Mathias Berger; C Bordi; H J Cüppers; P Berchtold; F A Gries; H Münterfering; R Sailer; H Zimmermann; L Orci
Functional and morphologic characterization of human insulinomas.
Diabetes 1983;32(10):921-31.
1983: F W Kemmer; G E Sonnenberg; H J Cüppers; Mathias Berger
[Absorption kinetics of semisynthetic human insulin and biosynthetic human insulin].
MMW, Münchener medizinische Wochenschrift 1983;Suppl 1():S85-90.
1983: Mathias Berger; K M Pirke; P Doerr; C Krieg; D von Zersseen
Influence of weight loss on the dexamethasone suppression test.
Archives of general psychiatry 1983;40(5):585-6.
1983: G E Sonnenberg; F W Kemmer; H J Cüppers; Mathias Berger
Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
Diabetes care 1983;6 Suppl 1():35-9.
1982: F W Kemmer; G Sonnenberg; H J Cüppers; Mathias Berger
Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin.
Diabetes care 1982;5 Suppl 2():23-8.
1982: Mathias Berger; P Doerr; R Lund; T Bronisch; Detlev von Zerssen
Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype?
Biological psychiatry 1982;17(11):1217-42.
1982: Mathias Berger; H J Cüppers; H Hegner; V Jörgens; P Berchtold
Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.
Diabetes care 1982;5(2):77-91.
1982: H J Cüppers; D Erdmann; H Schubert; P Berchtold; Mathias Berger
Glucose tolerance, serum insulin, and serum lipids in athletes.
Current problems in clinical biochemistry 1982;11():155-65.
1981: P Berchtold; H J Cüppers; Mathias Berger
[Diuretics, serum glucose and diabetes mellitus].
Deutsche medizinische Wochenschrift (1946) 1981;106(50):1712-4.
1980: F Leidinger; V Jörgens; E Chantelau; P Berchtold; Mathias Berger
[Blood-sugar self control. A means for the diabetic of controlling his metabolic management. Quality control of a battery-run pocket size reflectometer (glucose-meter)].
Fortschritte der Medizin 1980;98(28):1041-4.
1980: Mathias Berger; V Jörgens; H J Cüppers; F W Kemmer; P Berchtold
[Effects on glycoregulation of muscular activity as a function of its intensity and duration].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1980;():117-29.